Immunology and Microbiology
Aggregatibacter Actinomycetemcomitans
35%
Blood Plasma
9%
Caspase
7%
Cell Damage
9%
Cell Metabolism
14%
Choroid Plexus
14%
Complement Activation
7%
Complement Membrane Attack Complex
7%
Complement System
7%
Cytokine
14%
Cytolysis
16%
Cytotoxicity
7%
Erythrocyte
57%
Erythrocyte Volume
16%
Escherichia coli
100%
Guinea Pig
7%
Hemolysin
97%
Immune Response
9%
Integrin
14%
Interleukin-1
7%
Ion Transport
14%
Knockout Mouse
14%
Monocyte
14%
Mouse
42%
Murine
7%
Overall Survival
14%
Phagocytosis
6%
Platelet
27%
Proinflammatory Cytokine
10%
Pyelonephritis
6%
Sheep
7%
Staphylococcus Aureus
7%
Thrombocyte Activation
14%
Urinary Tract
10%
Uropathogenic Escherichia Coli
20%
Virulence Factor
13%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Triphosphate
16%
Adrenergic Receptor Stimulating Agent
7%
Aggregatibacter Actinomycetemcomitans
17%
Alpha Adrenergic Receptor
16%
Apnea
14%
Arabinoside
14%
Beta Adrenergic Receptor
11%
Combretastatin
14%
Combretastatin A4
14%
Crotalus
14%
Crotalus durissus
14%
Cytokine
12%
Disseminated Intravascular Clotting
6%
Epinephrine
28%
Escherichia coli
45%
Hemoglobins
7%
Hemolysin
45%
Hydralazine
6%
Hypoxia
14%
Infection
5%
Isoprenaline
23%
Knockout Mouse
14%
Leukotoxin
21%
Mouse
13%
Neoplasm
5%
Overall Survival
14%
Phenylephrine
23%
Purinergic P2 Receptor
21%
Purinergic P2X Receptor
30%
Purinergic P2X1 Receptor
28%
Purinergic P2X4 Receptor
14%
Purinergic P2X7 Receptor
14%
Receptor
11%
Receptor Antagonist
16%
Receptor Blocking Agent
14%
Sepsis
18%
Sinus Arrhythmia
14%
Tachycardia
7%
Teleost
14%
Urinary Tract Infection
5%
Uropathogenic Escherichia Coli
8%
Urosepsis
14%
Medicine and Dentistry
Adrenergic Stimulation
14%
Alpha Adrenergic Receptor
8%
Arabinoside
14%
Beta Adrenergic Receptor
5%
Breathing
14%
Cardiovascular System
14%
Central Venous Pressure
11%
Epinephrine
13%
Escherichia coli
14%
Gill
9%
Heart Function
14%
Hemolysin
14%
Hypoxia
18%
Infusion
7%
Isoprenaline
10%
Muscle Function
5%
Muscle Relaxation
5%
Neoplasm
14%
Neuromuscular Blocking
14%
Neuromuscular Blocking Agent
14%
Overall Survival
14%
Phenylephrine
10%
Platelet
14%
Positron Emission Tomography
14%
Purinergic P2X1 Receptor
14%
Radioactive Tracer
11%
Receptor Antagonist
6%
Receptor Blocking Agent
14%
Skeletal Muscle
14%
Stroke Volume
22%
Tumor Model
14%
Urosepsis
14%
Vein Tone
18%
Venous Circulation
14%